Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-003370
Filing Date
2021-02-26
Accepted
2021-02-26 08:57:24
Documents
111
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrsn-20201231.htm   iXBRL 10-K 2267651
2 EX-21.1 exhibit21110kfy2020q4.htm EX-21.1 3557
3 EX-23.1 exhibit23110kfy2020q4.htm EX-23.1 5340
4 EX-31.1 exhibit31110kfy2020q4.htm EX-31.1 9889
5 EX-31.2 exhibit31210kfy2020q4.htm EX-31.2 10190
6 EX-32.1 exhibit32110kfy2020q4.htm EX-32.1 6331
12 mrsn-20201231_g1.jpg GRAPHIC 142312
13 mrsn-20201231_g10.jpg GRAPHIC 337882
14 mrsn-20201231_g2.jpg GRAPHIC 63818
15 mrsn-20201231_g3.jpg GRAPHIC 130677
16 mrsn-20201231_g4.jpg GRAPHIC 44219
17 mrsn-20201231_g5.jpg GRAPHIC 53590
18 mrsn-20201231_g6.jpg GRAPHIC 95079
19 mrsn-20201231_g7.jpg GRAPHIC 231280
20 mrsn-20201231_g8.jpg GRAPHIC 76511
21 mrsn-20201231_g9.jpg GRAPHIC 38780
  Complete submission text file 0001628280-21-003370.txt   12802136

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20201231.xsd EX-101.SCH 73016
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20201231_cal.xml EX-101.CAL 105682
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20201231_def.xml EX-101.DEF 337061
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20201231_lab.xml EX-101.LAB 831534
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20201231_pre.xml EX-101.PRE 550650
22 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20201231_htm.xml XML 1544571
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38129 | Film No.: 21684017
SIC: 2834 Pharmaceutical Preparations